Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Nevens, Frederik*" or (type exact bookEditor and editor="Nevens, Frederik*")

Add to list
Milder disease stage in patients with primary biliary cholangitis over a 44-year period : a changing natural history

Fiorella Murillo Perez, Jorn C Goet, Willem J Lammers, Aliya Gulamhusein, Henk R van Buuren, Cyriel Y Ponsioen, Marco Carbone, Andrew Mason, Christophe Corpechot, Pietro Invernizzi, et al.

(2018) HEPATOLOGY. 67(5). p.1920-1930
Add to list
Pharmacokinetic interactions between simeprevir and ledipasvir in treatment naive hepatitis C virus genotype 1-Infected patients without cirrhosis treated with a simeprevir-sofosbuvir-ledipasvir regimen

Stefan Bourgeois, Yves Horsmans, Frederik Nevens, Hans Van Vlierberghe (UGent) , Christophe Moreno, Maria Beumont, Leen Vijgen, Veerle van Eygen, Donghan Luo, Vera Hillewaert, et al.

(2017) ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 61(12).
Add to list
- Conference Paper
- C3
Time trends in major hepatic complications in primary biliary cholangitis : incidence and transplant-free survival

Maren H Harms, Willem J Lammers, Douglas Thorburn, Christophe Corpechot, Pietro Invernizzi, Harry L Janssen, Pier Maria Battezzati, Frederik Nevens, Keith D Lindor, Annarosa Floreani, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.40A-40A
Add to list
- Conference Paper
- C3
Bilirubin is predictive of transplant-free survival even within the normal range in primary biliary cholangitis patients

Carla F Murillo Perez, Aliya Gulamhusein, Henk R van Buuren, Willem J Lammers, Jorn C Goet, Cyriel Y Ponsioen, Marco Carbone, Andrew Mason, Christophe Corpechot, Marlyn J Mayo, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.41A-42A
Add to list
- Conference Paper
- C3
Time-dependent factors associated with diminished transplant-free survival in patients with primary biliary cholangitis and an optimal response to ursodeoxycholic acid after one year of treatment

Willem J Lammers, Jorn C Goet, Marlyn J Mayo, Ann-Arosa Floreani, Pietro Invernizzi, Maren H Harms, Christophe Corpechot, Keith D Lindor, Cyriel Y Ponsioen, Harry L Janssen, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.157A-158A
Add to list
- Conference Paper
- C3
Recurrence of primary biliary cholangitis after liver transplantation affects graft survival : a multi-center study from the Global PBC study group

Aldo J Montano-Loza, Bettina E Hansen, Davide Roccarina, Douglas Thorburn, Palak J Trivedi, Gideon Hirschfield, Christophe Corpechot, Raoul Poupon, Jerome Dumortier, Alexie Bosch, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.163A-164A
Add to list
- Conference Paper
- C3
Moving from early to moderate or advanced biochemical disease stage during follow-up is associated with an increasing risk of clinical events in primary biliary cholangitis patients

Nikolaos K Gatselis, Jorn C Goet, Kalliopi Zachou, Willem J Lammers, Harry L Janssen, Gideon Hirschfield, Christophe Corpechot, Keith D Lindor, Pietro Invernizzi, Marlyn J Mayo, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.169A-170A
Add to list
Belgian experience with direct acting antivirals in people who inject drugs

Rob Bielen, Christophe Moreno, Hans Van Vlierberghe (UGent) , Stefan Bourgeois, Jean-Pierre Mulkay, Thomas Vanwolleghem, Wim Verlinden, Christian Brixko, Jochen Decaestecker, Chantal De Galocsy, et al.

(2017) DRUG AND ALCOHOL DEPENDENCE. 177. p.214-220
Add to list
- Journal Article
- A1
- open access
Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection

Stefan Bourgeois, Hans Van Vlierberghe (UGent) , Christophe Moreno, Hans Orlent, Frederik Nevens, Keikawus Arastéh, Yves Horsmans, Jörn M Schattenberg, Peter Buggisch, Sven Francque, et al.

(2017) BMC GASTROENTEROLOGY. 17.
Add to list
- Journal Article
- A1
- open access
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients : results from the GUARD-C cohort

Graham R. Foster, Carmine Coppola, Moutaz Derbala, Peter Ferenci, Alessandra Orlandini, K. Rajender Reddy, Ludovico Tallarico, Mitchell L. Shiffman, Silke Ahlers, Georgios Bakalos, et al.

(2016) PLOS ONE. 11(3).

← Previous

Academic Bibliography

Milder disease stage in patients with primary biliary cholangitis over a 44-year period : a changing natural history

Pharmacokinetic interactions between simeprevir and ledipasvir in treatment naive hepatitis C virus genotype 1-Infected patients without cirrhosis treated with a simeprevir-sofosbuvir-ledipasvir regimen

Time trends in major hepatic complications in primary biliary cholangitis : incidence and transplant-free survival

Bilirubin is predictive of transplant-free survival even within the normal range in primary biliary cholangitis patients

Time-dependent factors associated with diminished transplant-free survival in patients with primary biliary cholangitis and an optimal response to ursodeoxycholic acid after one year of treatment

Recurrence of primary biliary cholangitis after liver transplantation affects graft survival : a multi-center study from the Global PBC study group

Moving from early to moderate or advanced biochemical disease stage during follow-up is associated with an increasing risk of clinical events in primary biliary cholangitis patients

Belgian experience with direct acting antivirals in people who inject drugs

Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection

Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients : results from the GUARD-C cohort

Contents

Support

Contact